Shattuck Labs (STTK) Shares Outstanding (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Shares Outstanding (Entity) of $112.2 million for Q1 2026, up 134.31% year-over-year from $47.9 million in Q1 2025, and up 77.36% quarter-over-quarter from $63.3 million in Q4 2025.
Shattuck Labs (STTK) Shares Outstanding (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Shares Outstanding (Entity) for 8 consecutive years, with $112.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 134.31% year-over-year to $112.2 million; the TTM figure through Mar 2026 stood at $112.2 million (up 134.31% YoY), while the FY2025 annual figure was $63.3 million, up 32.62% from the prior year.
- Shares Outstanding (Entity) advanced to $112.2 million in Q1 2026 per STTK's latest filing, from $63.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $112.2 million in Q1 2026 and bottomed at $42.4 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $51.1 million across 5 years, with a median of $47.5 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 0.12% — and 2026, when it surged 134.31%.
- Shattuck Labs' Shares Outstanding (Entity) stood at $42.4 million in 2022, then gained by 11.49% to $47.3 million in 2023, then advanced by 0.96% to $47.7 million in 2024, then jumped by 32.62% to $63.3 million in 2025, then surged by 77.36% to $112.2 million in 2026.
- Business Quant data shows STTK's Shares Outstanding (Entity) at $112.2 million in Q1 2026, $63.3 million in Q4 2025, and $63.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 129.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129.78 Mn |
| Mar 31, 2026 | 112.23 Mn |
| Dec 31, 2025 | 69.58 Mn |
| Sep 30, 2025 | 72.18 Mn |
| Jun 30, 2025 | 51.00 Mn |
| Mar 31, 2025 | 50.97 Mn |
| Dec 31, 2024 | 50.76 Mn |
| Sep 30, 2024 | 50.83 Mn |
| Jun 30, 2024 | 50.79 Mn |
| Mar 31, 2024 | 50.57 Mn |
| Dec 31, 2023 | 42.60 Mn |
| Sep 30, 2023 | 42.48 Mn |
| Jun 30, 2023 | 42.47 Mn |
| Mar 31, 2023 | 42.44 Mn |
| Dec 31, 2022 | 42.38 Mn |
| Sep 30, 2022 | 42.39 Mn |
| Jun 30, 2022 | 42.38 Mn |
| Mar 31, 2022 | 42.36 Mn |
| Dec 31, 2021 | 42.03 Mn |
| Sep 30, 2021 | 42.16 Mn |